rFXIII

recombinant factor XIII · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rFXIII, covering 2014-08-05 to 2014-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis [Phase 2]

See pricing